Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP782420.RA8gR9VLrJl6wK8b8WxnohRWcwOIxIW2MGakg6xqw7_j4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP782420.RA8gR9VLrJl6wK8b8WxnohRWcwOIxIW2MGakg6xqw7_j4130_assertion type Assertion NP782420.RA8gR9VLrJl6wK8b8WxnohRWcwOIxIW2MGakg6xqw7_j4130_head.
- NP782420.RA8gR9VLrJl6wK8b8WxnohRWcwOIxIW2MGakg6xqw7_j4130_assertion description "[Some of them, including Tumor Necrosis Factor-alpha, Interferon-gamma-inducible Protein-10, Monocyte Chemotactic Protein-1 and Interleukin-8, are increased in AD and in Mild Cognitive Impairment (MCI), considered the prodromal stage of AD, suggesting that these modifications occur very early during the development of the disease, possibly explaining the failure of trials with anti-inflammatory agents in patients with severe AD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP782420.RA8gR9VLrJl6wK8b8WxnohRWcwOIxIW2MGakg6xqw7_j4130_provenance.
- NP782420.RA8gR9VLrJl6wK8b8WxnohRWcwOIxIW2MGakg6xqw7_j4130_assertion evidence source_evidence_literature NP782420.RA8gR9VLrJl6wK8b8WxnohRWcwOIxIW2MGakg6xqw7_j4130_provenance.
- NP782420.RA8gR9VLrJl6wK8b8WxnohRWcwOIxIW2MGakg6xqw7_j4130_assertion SIO_000772 20021370 NP782420.RA8gR9VLrJl6wK8b8WxnohRWcwOIxIW2MGakg6xqw7_j4130_provenance.
- NP782420.RA8gR9VLrJl6wK8b8WxnohRWcwOIxIW2MGakg6xqw7_j4130_assertion wasDerivedFrom befree-2016 NP782420.RA8gR9VLrJl6wK8b8WxnohRWcwOIxIW2MGakg6xqw7_j4130_provenance.
- NP782420.RA8gR9VLrJl6wK8b8WxnohRWcwOIxIW2MGakg6xqw7_j4130_assertion wasGeneratedBy ECO_0000203 NP782420.RA8gR9VLrJl6wK8b8WxnohRWcwOIxIW2MGakg6xqw7_j4130_provenance.